ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

HIV-DART 2024

Completed
Institution
Emory University, GA
Principal investigator
Raymond Felix Schinazi
Funding
$30K
Duration
2024–2025
Open portfolio

Moonbase score

Still being scored

Abstract

Abstract/ Project Summary Thanks to advances in antiretroviral therapy, the face of HIV and AIDS has been gradually and meaningfully transformed from a deadly disease, into a chronic condition that is managed with careful adherence to life-long treatment regimens. The need for improved drugs, with fewer side effects, improved adherence, and more favorable pharmacokinetics increases as the number of infected individuals on long-term therapy continues to rise. Importantly, the quest for an HIV cure continues to gain momentum as we learn more about viral reservoirs and mechanisms of viral persistence. HIV-DART is a biennial conference for physicians, clinicians, nurses, scientists, and clinical researchers that will focus on the latest discoveries in these areas. Specific Aims: 1. To gather cross-disciplinary professionals such as clinicians, health care workers, researchers, and basic scientists together in an interactive workshop setting to share and discuss the latest developments in the field of HIV; 2. To facilitate the neutral and balanced exchange of scientific knowledge with regard to antiviral drug development, vaccine development, and recent progress in curative strategies; 3. To enhance the training of young scientists such as graduate students and post-doctoral fellows and provide increased opportunities for underrepresented scientists and health care workers through attendee scholarships. Educational Objectives: 1. Advances in antiretroviral therapy, long-acting formulations, and injectable drugs for HIV; 2. Novel approaches to suppress and eliminate HIV reservoirs; 3. HIV cure strategies; 4. HIV in the aging population; 5. Novel vaccines and immunological therapies in development; 6. Treatment as prevention and PrEP; 7. HIV co-infections with HCV, HBV, and/or SARS-CoV-2. Design & Methods: HIV-DART 2024 will take place over 2.5 days, at a location that is easily accessed by both national and international delegates. The program will include plenary lectures, oral abstract presentations, discussion panels, and a debate. This ACCME-accredited program will provide ample time for formal and informal networking and discussion amongst the delegates during the poster session, coffee breaks, and meal breaks.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESR13Special Emphasis Panel[ZAI1 RD-D (S2)]latestdiscussionantiretroviral therapyantiretroviralhiv curereservoirshivbreaks

Questions for Emory University

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.